白介素-6水平在多发性骨髓瘤CTX-VTD方案治疗前后对比研究  

IL-6 Levels Before and After the Comparative Study of Multiple Myeloma CTX-VTD Therapy

作　　者：董霞[1] 王丽茹[1] 王英慧[1] 刘葳[1] 史恩红[1] 

机构地区：[1]黑龙江省医院血液风湿科,黑龙江哈尔滨150036

出　　处：《中国继续医学教育》2016年第26期164-165,共2页China Continuing Medical Education

摘　　要：目的对比白介素-6水平在多发性骨髓瘤CTX-VTD方案治疗前后差异并对其进行探究。方法选取使用CTX-VTD方案治疗在我院诊治的20例多发性骨髓瘤患者为研究对象,对比诊治前后白介素-6水平。结果白介素-6水平诊治后低于诊治前,差异具有统计学意义,即P<0.05。结论 CTX-VTD方案治疗多发性骨髓瘤有效,能够显著减少患者白介素-6水平。Objective To compare the IL-6 level before and after CTX- VTD multiple myeloma treatment and exploring its differences. Methods 20 cases of multiple myeloma patients were CTX-VTD treatment in our hospital were chosen and compared before and after treatment IL-6 levels. Results IL-6 level was significantly lower than that after treatment before treatment, the difference was statistically significant, P〈0.05. Conclusion CTX-VTD treatment of multiple myeloma and effective, can significantly reduce the patient IL-6 levels.

关 键 词：白介素-6 多发性骨髓瘤 CTX-VTD方案 

分 类 号：R733[医药卫生—肿瘤]